Intern, Discovery Data Science (Project: Data-Driven Discovery of Tumor-Specific Targets for Antibody Therapeutic Development)

Genmab | Utrecht | NL

Welcome to the Latest Job Vacancies Site 2025 and at this time we would like to inform you of the Latest Job Vacancies from the Genmab with the position of Intern, Discovery Data Science (Project: Data-Driven Discovery of Tumor-Specific Targets for Antibody Therapeutic Development) - Genmab which was opened this.

If this job matches your qualifications, please send your application directly through our latest Job site. Indeed, every job is not easy to apply because it must meet several qualifications and requirements that we must meet in accordance with the standard criteria of the Company who are looking for potential candidates to work. Good job information Intern, Discovery Data Science (Project: Data-Driven Discovery of Tumor-Specific Targets for Antibody Therapeutic Development) - Genmab below matches your qualifications.

...

At Genmab, were committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

Why Genmab

Be part of the extra[not]ordinary®: This is our unique word meaning we go way beyond what is usual; to be remarkable; proudly unique and authentic. This is your opportunity to make a profound difference with one of the worlds top companies solely dedicated to antibody therapeutics - a people-charged biotech innovation powerhouse rooted in science and inspired by patients.

Our internship program provides interns with hands-on experience and meaningful projects that directly contribute to our companys goals. Additionally, we believe that our program offers not just a chance to learn but also the opportunity to grow, network, and play a critical role in our efforts to make a difference for patients, every single day!

The Role

Single-cell RNA sequencing has transformed cancer research by enabling the analysis of individual tumor and immune cells at unprecedented depth. At Genmab, we leverage single-cell RNA sequencing to better understand the tumor microenvironment and advance the development of antibody-based therapeutics. As a Data Science intern, you will work closely with our Target and Product Discovery teams, where you will be trained in performing advanced single-cell data analysis, extracting meaningful insights to identify tumor-specific targets in endometrial cancer. This internship offers hands-on experience in data analysis, project planning, and scientific communication within a dynamic biotech environment. The specific research questions for these projects are still being defined, providing flexibility for you to shape your contributions based on your expertise and interests.

Responsibilities

  • Perform advanced data analysis of single-cell sequencing tumor datasets.
  • Translate findings into insights to inform antibody product discovery.
  • Communicate findings effectively through reports and presentations.

Requirements

  • Enrolled in a Masters program in Molecular Biology, Biomedical Sciences, Bioinformatics, or a related field at a University in the Netherlands.
  • Experience with Python and/or R programming.
  • You have a foundational knowledge of cancer biology and/or immunology.
  • You have experience in, or a strong interest in learning, single-cell data analysis and antibody drug discovery.
  • You enjoy working collaboratively in a multidisciplinary team.
  • Excellent communication and collaboration skills in English.
  • Previous programming experience, ideally with the development of your own package.

Preferred Qualifications, Capabilities, and Skills

  • Knowledge of AI techniques applied to chemical compound characterization, target discovery, and single-cell data analysis.
  • Experience with biomedical or chemical research datasets.
  • Familiarity with immuno-oncology, gynecological cancers.
  • Previous industry experience or internship in a related field.

General Internship Information

  • Internship duration: 6-12 months.
  • Start date: May/June 1st.
  • Location: Utrecht, Netherlands
  • Hybrid schedule: 3 days in the office, 2 days remote per week.

Whats Next?

Help us learn about you by submitting a complete and thoughtful application, including your resume. Your application and resume are our first introduction to you, so please complete all relevant application questions to provide as much information as possible.

We will review each submission as quickly as possible to determine whether you meet the qualifications for the role. Due to the volume of applications, we cannot respond to inquiries regarding application status. If you advance to the next step, you will receive an invitation for further discussion. The final step includes interviews with hiring team members, after which we will communicate final decisions to all interviewed candidates.

We look forward to receiving your application and exploring the possibility of you joining our team to contribute to the advancement of antibody therapeutics!

About You

  • You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
  • You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
  • You are a generous collaborator who can work in teams with diverse backgrounds
  • You are determined to do and be your best and take pride in enabling the best work of others on the team
  • You are not afraid to grapple with the unknown and be innovative
  • You have experience working in a fast-growing, dynamic company (or a strong desire to)
  • You work hard and are not afraid to have a little fun while you do so

Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether youre in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmabs vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.

Our commitment to diversity, equity, and inclusion

We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmabs policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.


Information :

  • Company : Genmab
  • Position : Intern, Discovery Data Science (Project: Data-Driven Discovery of Tumor-Specific Targets for Antibody Therapeutic Development)
  • Location : Utrecht
  • Country : NL

How to Submit an Application:

After reading and knowing the criteria and minimum requirements for qualifications that have been explained from the Intern, Discovery Data Science (Project: Data-Driven Discovery of Tumor-Specific Targets for Antibody Therapeutic Development) job info - Genmab Utrecht above, thus jobseekers who feel they have not met the requirements including education, age, etc. and really feel interested in the latest job vacancies Intern, Discovery Data Science (Project: Data-Driven Discovery of Tumor-Specific Targets for Antibody Therapeutic Development) job info - Genmab Utrecht in 2025-03-06 above, should as soon as possible complete and compile a job application file such as a job application letter, CV or curriculum vitae, FC diploma and transcripts and other supplements as described above, in order to register and take part in the admission selection for new employees in the company referred to, sent via the Next Page link below.

Next Process

Attention - In the recruitment process, legitimate companies never withdraw fees from candidates. If there are companies that attract interview fees, tests, ticket reservations, etc. it is better to avoid it because there are indications of fraud. If you see something suspicious please contact us: support@jobthird.com

Post Date : 2025-03-06